Hydroxyzine hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-883 -
Package NDC
76420-883-01 -
Package NDC
76420-883-05 -
Package NDC
76420-883-10 -
Package NDC
76420-883-30 -
Package NDC
76420-883-60 -
Package NDC
76420-883-90 -
Application number
ANDA204279 -
SPL ID
2979cc3d-941b-4936-e063-6394a90ab8f8 -
SPL set ID
4f3266f4-00a6-4c0c-bff2-e606913de894 -
UNII
76755771U3 -
RxCUI
995218 -
RxCUI
995258 -
RxCUI
995281
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- Hydroxyzine hydrochloride
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Hydroxyzine hydrochloride",
"splId": "2979cc3d-941b-4936-e063-6394a90ab8f8",
"labels": [
{
"setId": "4f3266f4-00a6-4c0c-bff2-e606913de894",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f3266f4-00a6-4c0c-bff2-e606913de894",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4f3266f4-00a6-4c0c-bff2-e606913de894"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (76420-883-01)",
"package_ndc": "76420-883-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20241217"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (76420-883-05)",
"package_ndc": "76420-883-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20241217"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (76420-883-10)",
"package_ndc": "76420-883-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20241217"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (76420-883-30)",
"package_ndc": "76420-883-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20241217"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (76420-883-60)",
"package_ndc": "76420-883-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20241217"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (76420-883-90)",
"package_ndc": "76420-883-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20241217"
}
],
"productId": "76420-883_2979cc3d-941b-4936-e063-6394a90ab8f8",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "76420-883",
"deaSchedule": null,
"genericName": "Hydroxyzine hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HYDROXYZINE DIHYDROCHLORIDE",
"strength": "50 mg/1"
}
],
"applicationNumber": "ANDA204279",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20140820",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"76755771U3"
],
"rxcui": [
"995218",
"995258",
"995281"
],
"spl_set_id": [
"4f3266f4-00a6-4c0c-bff2-e606913de894"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-883_2979cc3d-941b-4936-e063-6394a90ab8f8"